{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T07:27:55Z","timestamp":1777447675230,"version":"3.51.4"},"reference-count":66,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2023,12]]},"abstract":"<jats:p>Telemedicine has become a substantial part of abortion care in recent years. In this review, we discuss the history and regulatory landscape of telemedicine for medication abortion in the United States, different models of care for telemedicine, and the safety and effectiveness of medication abortion via telemedicine, including using history-based screening protocols for medication abortion without ultrasound. We also explore the acceptability of telemedicine for patients and their perspectives on its benefits, as well as the use of telemedicine for other parts of abortion care. Telemedicine has expanded access to abortion for many, although there remain limitations to its implementation.<\/jats:p>","DOI":"10.1097\/grf.0000000000000818","type":"journal-article","created":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T16:39:07Z","timestamp":1698856747000},"page":"725-738","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":5,"title":["Telemedicine Abortion"],"prefix":"10.1097","volume":"66","author":[{"given":"Hayley","family":"Dunlop","sequence":"first","affiliation":[{"name":"The Ohio State University College of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anne-Marie","family":"Sinay","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, The Ohio State University, Columbus, Ohio"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Courtney","family":"Kerestes","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, The Ohio State University, Columbus, Ohio"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","published-online":{"date-parts":[[2023,9,22]]},"reference":[{"key":"R1-20250512"},{"key":"R2-20250512","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1056\/NEJMsb1612526","article-title":"Sixteen years of overregulation: time to unburden Mifeprex","volume":"376","author":"Raymond","year":"2017","journal-title":"N Engl J Med"},{"key":"R4-20250512","doi-asserted-by":"crossref","first-page":"e2122320","DOI":"10.1001\/jamanetworkopen.2021.22320","article-title":"Safety and efficacy of telehealth medication abortions in the US during the COVID-19 pandemic","volume":"4","author":"Upadhyay","year":"2021","journal-title":"JAMA Network Open"},{"key":"R5-20250512","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1097\/AOG.0000000000002212","article-title":"Safety of medical abortion provided through telemedicine compared with in person","volume":"130","author":"Grossman","year":"2017","journal-title":"Obstet Gynecol"},{"issue":"2 Pt 1","key":"R6-20250512","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1097\/AOG.0b013e318224d110","article-title":"Effectiveness and acceptability of medical abortion provided through telemedicine","volume":"118","author":"Grossman","year":"2011","journal-title":"Obstet Gynecol"},{"key":"R7-20250512","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1111\/1471-0528.15684","article-title":"Telemedicine for medical abortion: a systematic review","volume":"126","author":"Endler","year":"2019","journal-title":"BJOG"},{"key":"R8-20250512","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1177\/1357633X16659166","article-title":"Telemedicine provision of medical abortion in Alaska: through the provider\u2019s lens","volume":"23","author":"Grindlay","year":"2017","journal-title":"J Telemed Telecare"},{"key":"R9-20250512","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1097\/AOG.0000000000003357","article-title":"Medication abortion provided through telemedicine in four US states","volume":"134","author":"Kohn","year":"2019","journal-title":"Obstet Gynecol"},{"key":"R10-20250512","doi-asserted-by":"crossref","first-page":"1692","DOI":"10.1007\/s11605-020-04623-5","article-title":"Telemedicine: patient-provider clinical engagement during the COVID-19 pandemic and beyond","volume":"24","author":"Contreras","year":"2020","journal-title":"J Gastrointest Surg"},{"key":"R11-20250512","doi-asserted-by":"crossref","first-page":"100049","DOI":"10.1016\/j.conx.2020.100049","article-title":"Adoption of no-test and telehealth medication abortion care among independent abortion providers in response to COVID -19","volume":"2","author":"Upadhyay","year":"2020","journal-title":"Contracept X"},{"key":"R12-20250512","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.contraception.2021.04.010","article-title":"Changes to medication abortion clinical practices in response to the COVID-19 pandemic","volume":"104","author":"Tschann","year":"2021","journal-title":"Contraception"},{"key":"R13-20250512","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.contraception.2021.03.025","article-title":"Provision of medication abortion in Hawai \u2018i during COVID-19: Practical experience with multiple care delivery models","volume":"104","author":"Kerestes","year":"2021","journal-title":"Contraception"},{"key":"R14-20250512","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.contraception.2019.05.013","article-title":"TelAbortion: evaluation of a direct to patient telemedicine abortion service in the United States","volume":"100","author":"Raymond","year":"2019","journal-title":"Contraception"},{"key":"R15-20250512","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.contraception.2021.03.019","article-title":"Expansion of a direct-to-patient telemedicine abortion service in the United States and experience during the COVID-19 pandemic","volume":"104","author":"Chong","year":"2021","journal-title":"Contraception"},{"key":"R21-20250512","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.contraception.2021.04.020","article-title":"Federal, state, and institutional barriers to the expansion of medication and telemedicine abortion services in Ohio, Kentucky, and West Virginia during the COVID-19 pandemic","volume":"104","author":"Mello","year":"2021","journal-title":"Contraception"},{"key":"R22-20250512","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/j.contraception.2020.04.005","article-title":"Commentary: No-test medication abortion: a sample protocol for increasing access during a pandemic and beyond","volume":"101","author":"Raymond","year":"2020","journal-title":"Contraception"},{"key":"R23-20250512","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1363\/psrh.12210","article-title":"Person\u2010centered, high\u2010quality care from a distance: a qualitative study of patient experiences of TelAbortion, a model for direct\u2010to\u2010patient medication abortion by mail in the United States","volume":"54","author":"Kerestes","year":"2022","journal-title":"Perspect Sex Reprod Health"},{"key":"R24-20250512","doi-asserted-by":"crossref","first-page":"1464","DOI":"10.1111\/1471-0528.16668","article-title":"Effectiveness, safety and acceptability of no-test medical abortion (termination of pregnancy) provided via telemedicine: a national cohort study","volume":"128","author":"Aiken","year":"2021","journal-title":"BJOG"},{"key":"R25-20250512","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.contraception.2022.09.013","article-title":"Self-determination of eligibility for early medication abortion without ultrasound using a history-based tool: LMP-SURE","volume":"116","author":"Kerestes","year":"2022","journal-title":"Contraception"},{"key":"R27-20250512","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1111\/j.1471-0528.2010.02753.x","article-title":"Alternatives to routine ultrasound for eligibility assessment prior to early termination of pregnancy with mifepristone-misoprostol","volume":"118","author":"Bracken","year":"2011","journal-title":"BJOG"},{"key":"R28-20250512","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/j.contraception.2015.04.008","article-title":"Early medical abortion without prior ultrasound","volume":"92","author":"Raymond","year":"2015","journal-title":"Contraception"},{"key":"R29-20250512","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.contraception.2020.05.012","article-title":"A repeat dose of misoprostol 800 mcg following mifepristone for outpatient medical abortion at 64-70 and 71-77 days of gestation: A retrospective chart review","volume":"102","author":"Dzuba","year":"2020","journal-title":"Contraception"},{"key":"R31-20250512","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.contraception.2018.11.002","article-title":"Medical abortion in the late first trimester: a systematic review","volume":"99","author":"Kapp","year":"2019","journal-title":"Contraception"},{"key":"R32-20250512","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1097\/01.AOG.0000115511.14004.19","article-title":"Routine follow-up visits after first-trimester induced abortion","volume":"103","author":"Grossman","year":"2004","journal-title":"Obstet Gynecol"},{"key":"R33-20250512","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1097\/01.AOG.0000130839.61098.12","article-title":"Ectopic pregnancy and medical abortion","volume":"104","author":"Shannon","year":"2004","journal-title":"Obstet Gynecol"},{"key":"R34-20250512","doi-asserted-by":"crossref","first-page":"e31","DOI":"10.1097\/AOG.0000000000004082","article-title":"Medication abortion up to 70 days of gestation: ACOG Practice Bulletin, Number 225","volume":"136","author":"Creinin","year":"2020","journal-title":"Obstet Gynecol"},{"key":"R35-20250512","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1016\/j.contraception.2017.11.005","article-title":"Simplified medical abortion screening: a demonstration project","volume":"97","author":"Raymond","year":"2018","journal-title":"Contraception"},{"key":"R36-20250512","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1136\/bmjsrh-2020-200976","article-title":"Telemedicine medical abortion at home under 12 weeks\u2019 gestation: a prospective observational cohort study during the COVID-19 pandemic","volume":"47","author":"Reynolds-Wright","year":"2021","journal-title":"BMJ Sex Reprod Health"},{"key":"R37-20250512","doi-asserted-by":"crossref","first-page":"710.e1","DOI":"10.1016\/j.ajog.2021.11.1373","article-title":"Accuracy of self-assessment of gestational duration among people seeking abortion","volume":"226","author":"Ralph","year":"2022","journal-title":"Am J Obstet Gynecol"},{"key":"R38-20250512","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.contraception.2022.07.002","article-title":"Society of family planning committee consensus on Rh testing in early pregnancy","volume":"114","author":"Horvath","year":"2022","journal-title":"Contraception"},{"key":"R39-20250512","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.contraception.2014.03.016","article-title":"RU OK? The acceptability and feasibility of remote technologies for follow-up after early medical abortion","volume":"90","author":"Bracken","year":"2014","journal-title":"Contraception"},{"key":"R40-20250512","doi-asserted-by":"crossref","first-page":"1536","DOI":"10.1111\/1471-0528.15922","article-title":"Effectiveness, safety and acceptability of self\u2010assessment of the outcome of first\u2010trimester medical abortion: a systematic review and meta\u2010analysis","volume":"126","author":"Baiju","year":"2019","journal-title":"BJOG"},{"key":"R41-20250512","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1016\/j.ajog.2019.11.1244","article-title":"Follow-up strategies to confirm the success of medical abortion of pregnancies up to 10 weeks\u2019 gestation: a systematic review with meta-analyses","volume":"222","author":"Schmidt-Hansen","year":"2020","journal-title":"Am J Obstet Gynecol"},{"key":"R42-20250512","doi-asserted-by":"crossref","first-page":"100023","DOI":"10.1016\/j.conx.2020.100023","article-title":"Comparing telemedicine to in-clinic medication abortions induced with mifepristone and misoprostol","volume":"2","author":"Wiebe","year":"2020","journal-title":"Contraception: X"},{"key":"R43-20250512","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.contraception.2022.06.009","article-title":"Telemedicine for medical abortion service provision in Mexico: a safety, feasibility, and acceptability study","volume":"114","author":"Pe\u00f1a","year":"2022","journal-title":"Contraception"},{"key":"R44-20250512","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.contraception.2022.06.010","article-title":"Effectiveness and safety of a direct-to-patient telehealth service providing medication abortion targeted at rural and remote populations: Cross-sectional findings from Marie Stopes Australia","volume":"115","author":"Seymour","year":"2022","journal-title":"Contraception"},{"key":"R45-20250512","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1016\/S0140-6736(22)01474-X","article-title":"A telemedicine model for abortion in South Africa: a randomised, controlled, non-inferiority trial","volume":"400","author":"Endler","year":"2022","journal-title":"The Lancet"},{"key":"R46-20250512","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1111\/ajo.12800","article-title":"A direct\u2010to\u2010patient telemedicine abortion service in Australia: retrospective analysis of the first 18 months","volume":"58","author":"Hyland","year":"2018","journal-title":"Aust N Z J Obstet Gynaecol"},{"key":"R47-20250512","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1080\/13625187.2023.2170710","article-title":"Telemedicine medical abortion service in Georgia: an evaluation of a strategy with reduced number of in-Clinic visits","volume":"28","author":"Tsereteli","year":"2023","journal-title":"Eur J Contracept Reprod Health Care"},{"key":"R48-20250512","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1001\/jamainternmed.2022.0217","article-title":"Outcomes and safety of history-based screening for medication abortion","volume":"182","author":"Upadhyay","year":"2022","journal-title":"JAMA Internal Medicine"},{"key":"R49-20250512","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1097\/AOG.0000000000000897","article-title":"Mifepristone with buccal misoprostol for medical abortion: a systematic review","volume":"126","author":"Chen","year":"2015","journal-title":"Obstet Gynecol"},{"key":"R50-20250512","doi-asserted-by":"crossref","first-page":"705262","DOI":"10.3389\/fgwh.2021.705262","article-title":"Telehealth for addressing sexual and reproductive health and rights needs during the COVID-19 pandemic and beyond: a hybrid telemedicine-community accompaniment model for abortion and contraception services in Pakistan","volume":"2","author":"Shaikh","year":"2021","journal-title":"Front Glob Womens Health"},{"key":"R51-20250512","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.ijgo.2013.07.038","article-title":"Use of telemedicine for providing medical abortion","volume":"2","author":"Wiebe","year":"2014","journal-title":"Int J Gynaecol Obstet"},{"key":"R52-20250512","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1016\/j.contraception.2021.07.108","article-title":"Clinical and service delivery implications of omitting ultrasound before medication abortion provided via direct-to-patient telemedicine and mail in the US","volume":"104","author":"Anger","year":"2021","journal-title":"Contraception"},{"key":"R53-20250512","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1097\/AOG.0000000000005016","article-title":"No-test medication abortion: a systematic review","volume":"141","author":"Pearlman Shapiro","year":"2023","journal-title":"Obstet Gynecol"},{"key":"R54-20250512","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.contraception.2021.04.027","article-title":"Client satisfaction and experience of telemedicine and home use of mifepristone and misoprostol for abortion up to 10 weeks\u2019 gestation at British Pregnancy Advisory Service: a cross-sectional evaluation","volume":"104","author":"Meurice","year":"2021","journal-title":"Contraception"},{"key":"R55-20250512","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1136\/bmjsrh-2022-201502","article-title":"Should COVID-specific arrangements for abortion continue? The views of women experiencing abortion in Britain during the pandemic","volume":"48","author":"Lohr","year":"2022","journal-title":"BMJ Sex Reprod Health"},{"key":"R56-20250512","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1136\/bmjsrh-2020-200954","article-title":"Acceptability of no-test medical abortion provided via telemedicine during Covid-19: analysis of patient-reported outcomes","volume":"47","author":"Erlank","year":"2021","journal-title":"BMJ Sex Reprod Health"},{"key":"R57-20250512","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1136\/bmjsrh-2021-201259","article-title":"An observational study of patient experiences with a direct-to-patient telehealth abortion model in Australia","volume":"48","author":"Thompson","year":"2022","journal-title":"BMJ Sex Reprod Health"},{"key":"R58-20250512","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.contraception.2021.04.028","article-title":"\u201cIt was close enough, but it wasn\u2019t close enough\u201d: a qualitative exploration of the impact of direct-to-patient telemedicine abortion on access to abortion care","volume":"104","author":"Kerestes","year":"2021","journal-title":"Contraception"},{"key":"R59-20250512","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1136\/bmjsrh-2020-200612","article-title":"At-home telemedicine for medical abortion in Australia: a qualitative study of patient experiences and recommendations","volume":"46","author":"Fix","year":"2020","journal-title":"BMJ Sex Reprod Health"},{"key":"R60-20250512","doi-asserted-by":"crossref","first-page":"32","DOI":"10.21037\/mhealth-22-12","article-title":"Patient and provider experiences using a site-to-site telehealth model for medication abortion","volume":"8","author":"Ruggiero","year":"2022","journal-title":"Mhealth"},{"key":"R61-20250512","doi-asserted-by":"crossref","first-page":"1752","DOI":"10.1111\/1471-0528.16813","article-title":"Women\u2019s experiences of a telemedicine abortion service (up to 12 weeks) implemented during the coronavirus (COVID\u201019) pandemic: a qualitative evaluation","volume":"128","author":"Boydell","year":"2021","journal-title":"BJOG"},{"key":"R62-20250512","doi-asserted-by":"crossref","first-page":"e117","DOI":"10.1016\/j.whi.2012.12.002","article-title":"Women\u2019s and providers\u2019 experiences with medical abortion provided through telemedicine: a qualitative study","volume":"23","author":"Grindlay","year":"2013","journal-title":"Womens Health Issues"},{"key":"R63-20250512","first-page":"39","article-title":"Institute of Medicine (US) Committee on Quality of Health Care in America. Improving the 21st-Century Health Care System","volume":"2","year":"2001","journal-title":"Crossing the Quality Chasm: A New Health System for the 21st Century"},{"key":"R64-20250512","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1097\/GCO.0000000000000492","article-title":"The patient perspective: perceptions of the quality of the abortion experience","volume":"30","author":"Altshuler","year":"2018","journal-title":"Curr Opin Obstet Gynecol"},{"key":"R65-20250512","doi-asserted-by":"crossref","first-page":"1","DOI":"10.12688\/gatesopenres.12756.1","article-title":"Advancing a conceptual model to improve maternal health quality: the person-centered care framework for reproductive health equity","volume":"1","author":"Sudhinaraset","year":"2017","journal-title":"Gates Open Res"},{"key":"R66-20250512","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1136\/bmjsrh-2021-201263","article-title":"Adherence to treatment and prevalence of side effects when medical abortion is delivered via telemedicine: a prospective observational cohort study during COVID-19","volume":"48","author":"Reynolds-Wright","year":"2022","journal-title":"BMJ Sex Reprod Health"},{"key":"R67-20250512","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1097\/AOG.0000000000005192","article-title":"Patient perspectives regarding clinician communication during telemedicine compared with in-clinic abortion","volume":"141","author":"Godfrey","year":"2023","journal-title":"Obstet Gynecol"},{"key":"R68-20250512","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1089\/tmj.2022.0101","article-title":"Provider mistrust and telemedicine abortion care preferences among patients in Ohio, West Virginia, and Kentucky","volume":"29","author":"Rivlin","year":"2023","journal-title":"Telemed J E Health"},{"issue":"e1","key":"R69-20250512","doi-asserted-by":"crossref","first-page":"e38","DOI":"10.1136\/bmjsrh-2020-200972","article-title":"Miles and days until medical abortion via TelAbortion versus clinic in Oregon and Washington, USA","volume":"48","author":"Beardsworth","year":"2022","journal-title":"BMJ Sex Reprod Health"},{"key":"R70-20250512","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.contraception.2020.12.005","article-title":"Introduction of telemedicine for medication abortion: changes in service delivery patterns in two US states","volume":"103","author":"Kohn","year":"2021","journal-title":"Contraception"},{"key":"R72-20250512","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/j.whi.2021.02.007","article-title":"Pre-abortion informed consent through telemedicine vs. in person: differences in patient demographics and visit satisfaction","volume":"31","author":"Kaller","year":"2021","journal-title":"Womens Health Issues"},{"key":"R73-20250512","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.contraception.2019.08.010","article-title":"Characteristics of patients having telemedicine versus in-person informed consent visits before abortion in Utah","volume":"101","author":"Daniel","year":"2020","journal-title":"Contraception"},{"key":"R74-20250512","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/j.whi.2019.04.009","article-title":"Women\u2019s experiences using telemedicine to attend abortion information visits in Utah: a qualitative study","volume":"29","author":"Ehrenreich","year":"2019","journal-title":"Womens Health Issues"},{"key":"R75-20250512","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.contraception.2022.06.001","article-title":"Implementation of telemedicine preoperative visits for abortion procedures through 18 weeks gestation at a Northern California hospital-based center","volume":"114","author":"Matulich","year":"2022","journal-title":"Contraception"}],"container-title":["Clinical Obstetrics &amp; Gynecology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/GRF.0000000000000818","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,12]],"date-time":"2025-05-12T15:14:01Z","timestamp":1747062841000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/GRF.0000000000000818"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9,22]]},"references-count":66,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2023]]}},"URL":"https:\/\/doi.org\/10.1097\/grf.0000000000000818","relation":{},"ISSN":["0009-9201"],"issn-type":[{"value":"0009-9201","type":"print"}],"subject":[],"published":{"date-parts":[[2023,9,22]]}}}